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The objective of this study was to develop a sustained release dosage form of Trimetazidine 
dihydrochloride (TMZ) using a natural polymeric carrier prepared in a completely aqueous environment. 
TMZ was entrapped in calcium alginate beads prepared with sodium alginate by the ionotropic gelation 
method using calcium chloride as a crosslinking agent. The drug was incorporated either into preformed 
calcium alginate gel beads (sequential method) or incorporated simultaneously during the gelation stage 
(simultaneous method). The beads were evaluated for particle size and surface morphology using optical 
microscopy and SEM, respectively. Beads produced by the sequential method had higher drug entrapment. 
Drug entrapment in the sequential method was higher with increased CaCl2 and polymer concentration 
but lower with increased drug concentration. In the simultaneous method, drug entrapment was higher 
when polymer and drug concentration were increased and also rose to a certain extent with increase in 
CaCl2 concentration, where further increase resulted in lower drug loading. FTIR studies revealed that 
there is no interaction between drug and CaCl2. XRD studies showed that the crystalline drug changed 
to an amorphous state after formulation. Release characteristics of the TMZ loaded calcium alginate 
beads were studied in enzyme-free simulated gastric and intestinal fluid.
Uniterms: Sodium alginate. Calcium alginate beads. Trimetazidine dihydrochloride. Ionotropic gelation.
O objetivo deste estudo foi desenvolver forma de liberação controlada de dicloridrato de trimetazidina (TMZ) 
utilizando transportador plomérico natural em ambiente completamente aquoso. A TMZ foi presa em pérolas 
de alginato de cálcio preparadas com alginato de sódio pelo método de gelatinização ionotrópica, usando 
cloreto de cálcio como agente de formação de ligações cruzadas. O fármaco foi incorporado nas pérolas 
de gel de alginato de cálcio (método sequencial) ou incorporado, simultaneamente, durante o estágio de 
gelificação (método simultâneo). As pérolas foram avaliadas quanto ao tamanho das partículas e morfologia 
da superfície utilizando microscopia óptica de SEM, respectivamente. As pérolas produzidas pelo método 
sequencial apresentaram maior capacidade de inclusão. No método sequencial, a inclusão de fármaco foi 
maior com o aumento de CaCl2 e da concentração do plímero, mas menor com o aumento da concentração 
de fármaco. No método simultâneo, a inclusão de fármaco foi mais alta quando as concentrações de fármaco 
e plímero foram aumentadas e, também, atingiram certa extensão com aumento na concentração de CaCl2, 
cujo aumento posterior resultou em carga menor de fármaco. Estudos de FTIR revelaram que não há interação 
entre fármaco e CaCl2. Estudos de XRD mostraram que o fármaco mudou do estado cristalino para o amorfo 
após a formulação. As características de liberação de TMZ das pérolas carregadas com alginato de cálcio 
foram estudadas em fluidos simulados, gástrico e intestinal, livres de enzima.
Uniterms: Alginato de sódio. Beads de alginato de cálcio. Dicloridrato de trimetazidina. Gelatinização 
ionotrópica.
INTRODUCTION
TMZ, 1-[(2,3,4-tri-methoxyphenyl) methyl] pipe-
razine is a lesser known member of a new class of antian-
ginal drug (Manchanda, Krishnaswami, 1997). Unlike all 
the conventional antianginal agents, which affect haemo-
dynamic determinants of the myocardial oxygen supply-
demand balance, TMZ partly prevents intercellular meta-
bolic changes such as depletion of adenosine triphosphate 
(ATP) and phosphocreatine, accumulation of protons, and 
toxic free radical generation which results from ischemia 
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and reperfusion in the myocardium (Harpey et al., 1989). 
It selectively inhibit long chain 3-keto acyl-co-enzyme A 
(CoA) thiolase (3-KAT), which catalyses the terminal step 
of fatty acid beta-oxidation (Stanley, 2002).
Sodium alginate, a hydrophilic biopolymer obtained 
from brown seaweeds has been found to be highly pro-
mising with respect to drug delivery because of its high 
biological safety (Sriamornsak et al., 2007). Chemically, 
it is a polysaccharide composed of varying proportions of 
D-mannuronic acid (M) and L-guluronic acid (G) residues 
which are arranged in MM or GG blocks interspersed 
with MG blocks (Aslani, Kennedy, 1996). In addition to 
its use as a thickening, gel forming and colloidal stabili-
zing agent in the food and beverage industries, it is also 
used as a binder in tablet formulation (Liew et al., 2006). 
Its unique property of forming water insoluble calcium 
alginate gel through ionotropic gelation with Ca+2 ions 
under simple and mild conditions has made it possible 
to encapsulate both macromolecular agents (Polk et al., 
1994; Kikuchi et al., 1996; Bowersock et al., 1999) and 
low molecular weight therapeutic agents (Cui et al., 2001; 
Gonzalez-Rodriguez et al., 2002; Halder et al., 2005). The 
current uses of alginate-based devices are mainly related 
to encapsulation of various classes of therapeutic agents 
(El-Zatahry et al., 2006, Shishu et al., 2007; Mandal et 
al., 2010).
In this study, TMZ was incorporated into calcium 
alginate beads by sequential and simultaneous methods. 
The effect of polymer and CaCl2 concentration and that of 
TMZ concentration on drug entrapment (drug loading) and 
drug release characteristics were studied. The drug-loaded 
beads were also characterized using different techniques. 
MATERIAL AND METHOD
Trimetazidine dihydrochloride BP (Sun Pharmaceu-
ticals Pvt. Ltd., Vadodora, India ), Sodium alginate (Fluka) 
90 cps (1% w/v solution in water at 25 °C), and Calcium 
chloride dihydrate (E. Merck, India) were used. All other 
reagents were of analytical grade.
Preparation of beads
For bead formation, 50 mL of a 2-2.5% w/v aqueous 
solution of sodium alginate was introduced dropwise from 
a glass syringe with a size-22 needle into 100 mL of an 
aqueous calcium chloride solution being stirred at 400 rpm. 
The concentration of CaCl2 in the solution ranged from 1% 
w/v to 3% w/v. The stirring was continued for one hour 
and the calcium alginate beads were harvested by filtration, 
washed with distilled water, and air dried overnight.
Drug loading was carried out by two methods, desig-
nated as the sequential method and the simultaneous me-
thod. In the sequential method, calcium alginate beads were 
prepared as described in the previous paragraph. The wet 
beads were then immersed and stirred for 1hr in a solution 
containing TMZ (concentration ranging from 2-3 % w/v), 
filtered and washed with distilled water. TMZ-loaded cal-
cium alginate beads were obtained by subsequent drying. In 
the simultaneous method, the gelation of beads by calcium 
ions occurred simultaneously with the drug loading into the 
beads. The sodium alginate solution was introduced dro-
pwise into CaCl2 solutions (concentration ranging from 1-3 
%w/v) which also contained TMZ (concentration ranging 
from 2-3% w/v). After 1hr of interaction, the beads were 
removed from the counter ion solution. The drug loaded 
beads were washed and dried in a manner similar to that of 
blank beads (beads without drug).
Determination of drug content
For determination of drug content, 10 mg of beads 
were placed in 100 mL of double distilled water for 24 h. 
The filtered solution was measured for TMZ content 
using a UV spectrophotometer (GENESYS 10 UV Spec-
trophotometer, Thermo Corporation USA) at 202 nm. 
Drug content was computed using a calibration curve 
(R2 = 0.9998) prepared using solutions with concentrations 
of 1-6 µg/mL of TMZ.
The drug loading capacity of the beads was then 
computed according to the following equation:
 
Particle size distribution
The particle size determination of TMZ-loaded 
calcium alginate beads was carried out using an optical 
microscope along with a stage micrometer having an accu-
racy of 0.01 mm. A suspension of beads in liquid paraffin 
was prepared in a beaker and then one drop of this was 
dropped on a clean glass slide and covered with a cover 
slip. The average sizes of 100 beads were determined for 
each formulation using the calibration factor. The average 
diameter of the beads was calculated using the following 
formula: 
X = Average particle diameter, Xi = Individual diameter 
of beads, N = Number of beads.
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Scanning electron microscopy
The surface morphology of drug-loaded beads ob-
tained from various percentages of polymer, CaCl2 and 
drug were studied by using a scanning electron microscope 
(model JEOL JSM-6360, Japan). The beads were moun-
ted on an appropriate stub and then coated with carbon 
and gold (100 and 50 Å thickness respectively) sputter 
module in a vacuum evaporator in an argon atmosphere. 
The coated samples were then observed under a scanning 
electron microscope operated at 15 KV.
Fourier transform infra red analysis
The IR analysis of pure drug, polymer, and drug-
loaded beads prepared by both the methods were analyzed 
with FTIR spectrophotometer (Shimadzu FTIR-8400, 
Japan). All the samples were crushed with potassium 
bromide to get pellets at 600kg cm-2. Spectral scanning 
was done in the range of 400-4000 cm-1.
X-ray diffraction study
To understand the crystalline state of the drug in 
the polymer matrix, the X-ray diffraction pattern of drug-
loaded beads was performed and compared with that of 
pure drug. Powder forms of the samples were exposed to 
Cu radiation (30kv × 15mA) in a wide-angle X-ray diffrac-
tometer (Miniflex gonio Meter, Japan). The instrument 
was operated in continuous mode in increments of 1°/min 
and scanned over a 2Ɵ range of 10 to 90°.
In vitro drug release study
In vitro drug release studies were carried out in tripli-
cate using a USP II tablet dissolution test apparatus (model 
TDP-06P, Electro Lab, Mumbai, India) at 37±0.5 ºC and 
100 rpm. The beads of each formulation were placed in 
enzyme-free simulated gastric fluid (900 mL, 0.1N HCl, 
pH 1.2) for the first 2h and then in enzyme-free simulated 
intestinal fluid (900ml, Phosphate buffer solution, pH 
6.8) for 7 h. A 5 mL aliquot of the dissolution fluid was 
withdrawn at regular intervals of time and replaced imme-
diately with the same volume of fresh media. The aliquots, 
following suitable dilution, were analyzed for drug content 
using a spectrophotometer at 202 nm.
RESULTS AND DISCUSSION
In this investigation, a simple and inexpensive me-
thod was developed for the preparation of calcium alginate 
beads. Crosslinking of sodium alginate was done using 
CaCl2 and TMZ was loaded in the same. The various com-
positions of the formulation variables used for the present 
study are given in Table I.
Particle size was in the range of 1005 µm to 1075 µm 
for the beads obtained using the sequential method, and 
1057 µm to 1207 µm for those from the simultaneous 
method (Table 2). The particle size of the beads prepared 
by the simultaneous method decreased with higher CaCl2 
concentrations.
TABLE I - Composition of TMZ-loaded calcium alginate beads 
prepared by sequential and simultaneous method
Formulation 
code 
Formulation variables
Conc. of 
CaCl2 
(% w/v)
Conc. of 
sodium 
alginate 
(%w/v)
Drug 
(% w/v)
A1 1 2 2
A2 1 2 3
A3 1 2.5 2
A4 1 2.5 3
B1 2 2 2
B2 2 2 3
B3 2 2.5 2
B4 2 2.5 3
C1 3 2 2
C2 3 2 3
C3 3 2.5 2
C4 3 2.5 3
TABLE II  - Effect of sodium alginate, CaCl2, and TMZ 
concentration on particle size and drug loading
Formulation 
code
Mean particle size 
(µm±sd, n=3)
Drug loading 
(% ±sd , n=3)
Sequential method
A3 1065±0.01 53.22±0.02
B3 1060±0.01 58.15±0.01
C2 1057±0.01 45.21±0.02
C3 1005±0.25 62.15±0.01
C4 1075±0.01 56.28±0.05
Simultaneous method
A4 1207±0.5 46.89±0.01
B2 1158±0.75 52.02±0.03
B3 1151±0.25 55.32±0.01
B4 1106±0.25 58.28±0.02
C4 1057±0.50 55.60±0.03
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Scanning electron microscopy
The surface morphology of the prepared beads was 
studied by scanning electron microscopy (SEM) and the 
SEM photographs are depicted in Figure 1.
SEM photographs of the blank beads compared with 
drug loaded beads show a difference in surface morpho-
logy for both the sequential and simultaneous method. 
Smoothness increased when drug was loaded in the beads.
The SEM photographs of the drug-loaded beads (Fi-
gure 1[A]) show that the drug is dispersed in the polymeric 
matrix without having any coat, which further confirms 
that this system is a polymeric matrix system for beads 
prepared by both sequential and simultaneous methods.
The SEM photographs presented in Figure 1[B] also 
show differences in surface morphology of the prepared 
beads before and after the completion of in-vitro dissolu-
tion study for both the sequential and simultaneous me-
thods. The surface of beads after dissolution was rougher 
than before dissolution.
Drug loading
Drug loading was found to be in the range of 42-
62% for beads prepared by the sequential method and 
39-58% for the simultaneous method. Drug loading was 
found to be directly proportional to polymer concentration 
(El-Kamel et al., 2003) in both the methods. The effect of 
crosslinking agent and drug concentration on drug loading 
however, was different in both methods.
Higher loading efficiency was obtained as the con-
centration of alginate increased. This may be attributed to 
FIGURE 1 - [A] SEM photographs of TMZ-loaded calcium alginate beads prepared by the sequential method (a) Drug-loaded 
bead (b) After dissolution. [B] SEM photographs of TMZ loaded calcium alginate beads prepared by simultaneous method (c) 
Drug-loaded bead (d) after dissolution.
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FIGURE 2 - FTIR spectra of TMZ (A), Sodium alginate (B), TMZ-loaded beads prepared by sequential method (C), TMZ loaded-
beads prepared by simultaneous method (D).
the greater availability of active calcium binding sites in 
the polymeric chains and consequently, the greater degree 
of crosslinking as the quantity of sodium alginate increa-
sed (Yotsuyanagi et al., 1987). For the sequential method, 
batch C3 had the highest drug loading (62%). The use of 
drug concentrations greater than 2% w/v did not result in 
further enhancement of drug loading. 
It was observed that the efficiency of loading TMZ 
into the calcium alginate beads by the simultaneous me-
thod was lower than by the sequential method (Lim, Wan, 
1997). For the simultaneous method, batch B4 had the 
highest drug loading (58%). When the drug loading was 
carried out by the simultaneous method with the gelation 
of alginate by Ca+2, the counter ion solution contained both 
the drug molecule and CaCl2. The drug molecules and Ca
+2 
ions diffuse in the same direction, from the solution into 
the sodium alginate solution, and competed simultaneous-
ly for common binding sites along the alginate chains. The 
amount of associated Ca+2 ions (and the drug molecules) 
in the beads was a function of the concentration ratio of 
CaCl2: TMZ in the solution. 
Increase in CaCl2 concentration from 1 to 3% and 
polymer concentration from 2 to 2.5% resulted in an in-
crease in the drug entrapment from 53% to 62%, and from 
45% to 62%, respectively for the sequential method. Drug 
entrapment decreased from 62% to 42% when the drug 
concentration was increased from 2 -3% for the same. 
Similarly, in the simultaneous method increase in 
drug entrapment from 47% to 58%, from 52% to 58% 
and from 55% to 58% was observed for corresponding 
changes in the CaCl2, polymer and drug concentration, 
respectively.
Fourier transformed infra red analysis
FTIR spectral data were used to confirm the che-
mical stability of Trimetazidine in alginate beads. FTIR 
spectra of pure drug, sodium alginate, TMZ-loaded cal-
cium alginate beads prepared by sequential and simulta-
neous method were compared in Figure 2. FTIR spectra 
of TMZ show the characteristic bands of –OH stretching, 
-CH stretching, >C=O stretching, C-H bending and C-O-
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C stretching at 3440, 2995, 1605, 1417, and 1101 cm-1, 
respectively. The spectra obtained from drug-loaded beads 
prepared by both the methods, indicate the presence of the 
characteristic bands of the drug at almost the same wave 
number.
X-ray diffraction study
In order to confirm the physical state of the drug in 
the beads, data for the X-ray diffraction studies of the pure 
drug, polymer, empty beads and beads containing the drug 
is shown in Figure 3. No characteristic XRD pattern was 
observed in the case of drug-loaded beads. Thus, from the 
X-ray diffraction data of the drug-loaded beads, it can be 
inferred that the drug was not present in the crystalline 
state in the bead matrix but was in the amorphous state. 
This clearly indicated that changes in the crystalline state 
of the drug occurred during the preparation of the beads 
by this ionotropic gelation method. 
In-vitro drug release
The release profile of TMZ in enzyme-free simulated 
gastric fluid (SGF) followed by enzyme-free simulated in-
testinal fluid (SIF) from the calcium alginate beads prepared 
under different conditions are shown in Figures 4-6. The 
drug release from the alginate beads depends on the pene-
tration of the dissolution medium into the beads, swelling 
and dissolution of alginate matrix, and the dissolution of 
the drug subsequent to leaching through the swollen matrix. 
In SGF alginate beads prepared by the sequential method, 
TMZ releases about 30-40 % drug in the first 2 h. The rest 
of the drug then releases in the SIF, continuing for up to 9 h 
whereby it releases 82-89% of the drug. It was found that 
drug release is accompanied by a burst release which may 
be due to the highly water soluble nature of the drug.
Effect of polymer
To study the effect of sodium alginate concentra-
tion on TMZ release, two different concentrations, 2 and 
2.5% w/v were used. Figure 4 shows the influence of the 
concentration of sodium alginate solution on Trimetazi-
dine release behavior from calcium alginate-loaded beads 
prepared by the sequential and simultaneous methods. Lo-
wer concentrations of sodium alginate led to faster drug re-
lease, with 89.05±0.178% of drug release within 9 h using 
the sequential method. Increase in alginate concentration 
slowed the release rate. Thus, the results indicate that 
FIGURE 3 - X ray diffractogram of TMZ (A), Sodium alginate 
(B), TMZ-loaded beads prepared by sequential method(C), 
TMZ-loaded beads prepared by simultaneous method(D).
FIGURE 4 - Effect of sodium alginate concentration on TMZ 
release from calcium alginate beads (a) Sequential method (b) 
Simultaneous method. (Maximum SEM ±3.70%, n= 4).
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drug release was directly proportional to sodium alginate 
concentration (Yotsuyanagi et al., 1987; Basu, Rajendran, 
2008). The principal gelation or cross-linking of sodium 
alginate with CaCl2 is based on the tight junction between 
the guluronic acid residues (Rajinikanth et al., 2003). The 
number of the apparent cross-linking points formed within 
increases with increasing alginate concentration in the 
formulation. This can be correlated with the particle size 
studies where, as alginate concentration increased, particle 
size decreased, due to the formation of more a rigid and 
compact matrix, consequently retarding TMZ release.
In the case of TMZ-loaded calcium alginate beads 
prepared by the simultaneous method, similar behavior 
was also observed.
Effect of CaCl2
The release behavior of calcium alginate beads 
prepared by the sequential method with different con-
centrations of CaCl2 (1-3% w/v) is indicated in Figure 5. 
Drug release was sustained from 38% to 30% in SGF for 
2 h, and 89% to 82% in SIF fluid up to 9 h with increasing 
FIGURE 5 - Effect of CaCl2 concentration on TMZ release from 
calcium alginate beads (a) Sequential method (b) Simultaneous 
method. (Maximum SEM ±2.50%, n= 4).
CaCl2 concentration. Thus, in the sequential method, as the 
concentration of crosslinking agent increased, drug release 
decreased (El-Zatahry et al. 2006). Beads prepared with 
3% w/v CaCl2 showed the most sustained release effect 
due to more crosslinking resulting in the formation of a 
more rigid gel network and hence greater sustained release 
characteristics. It was confirmed by particle size studies, 
where the size of the beads was found to be smaller as the 
concentration of crosslinking agent increased (El-Kamel 
et al., 2003). It was also evident from the literature (Raji-
nikanth et al., 2003) that diffusion of drug from alginate 
matrix decreased as the concentration of CaCl2 solution 
increased in the sequential method, probably due to greater 
cross-linking with sodium alginate.
In the simultaneous method, TMZ release was sus-
tained from 30% to 37% in SGF for 2h, and from 93% to 
82% in SIF up to 9 h (Figure 5). But in case of the simul-
taneous method, 3% crosslinking agent did not show the 
highest sustained effect. This may be due to the low drug 
loading (Lim et al., 1997).
Effect of drug concentration
It was found that drug releases within the 1st hour 
were indicative of a burst effect. This could be attributed 
FIGURE 6 - Effect of TMZ concentration on TMZ release from 
calcium alginate beads (a) Sequential method (b) Simultaneous 
method. (Maximum SEM ±3.30%, n= 4).
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to the highly water soluble nature of the drug. A similar 
result was found by Ray et al., (Ray et al., 2008) during 
preparation of diltiazem resin complex-loaded carboxy-
methyl xanthan beads.
The effect of drug concentration during in-vitro 
drug release study does not affect the drug release from 
the calcium alginate beads. The drug concentration ranged 
from 2 to 3% w/v to study the effect of drug release sho-
wn in Figure 6. TMZ release from beads prepared by the 
sequential method (batch C3), which contained 2% w/v 
TMZ, shows a more sustained effect with drug loading of 
about 62%. 
However, in the case of the simultaneous method 
(batch B4), which contains 3% w/v drug, a more sustained 
effect with drug loading of about 58% was evident. Drug 
release was found to be highly dependent on drug loading.
CONCLUSION
Trimetazidine was entrapped in calcium alginate 
beads prepared with sodium alginate by the ionotropic 
gelation method, using calcium chloride as a crosslinking 
agent. The drug was incorporated by two methods, sequen-
tial and simultaneous methods. Beads produced by the for-
mer method had higher drug entrapment. The beads were 
evaluated for drug entrapment, particle size and release 
characteristics in enzyme-free simulated gastric and simu-
lated intestinal fluid. The drug entrapment in the sequential 
method increases with increased CaCl2 and polymer con-
centration but decreased with higher drug concentration. 
In the simultaneous method, drug entrapment was higher 
with polymer and drug concentration increase and rose to 
a certain extent with increase in the concentration of CaCl2 
and after further increase it decreased. Drug release was 
directly proportional to the polymer concentration for the 
drug-loaded beads prepared by both the methods. Increase 
in CaCl2 concentration retarded the drug release in the 
sequential method whereas for the simultaneous method 
the retardation in drug release occurred up to a certain 
concentration of CaCl2. The drug concentration exhibits 
a drug-loading dependent effect on the release behavior 
in both the methods.
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